These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38828373)

  • 1. Clinical Predictors of Bacteremia Outcome After Initial Empirical Antimicrobial Therapy in Patients with Hematological Malignancies: A Retrospective Analysis.
    Gao J; Zheng J; Zhang H; Wang J; Jing H
    Infect Drug Resist; 2024; 17():2099-2107. PubMed ID: 38828373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant
    Meng H; Han L; Niu M; Xu L; Xu M; An Q; Lu J
    Infect Drug Resist; 2022; 15():4241-4251. PubMed ID: 35959146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review.
    Park S; So H; Kim MN; Lee J
    BMC Infect Dis; 2022 Nov; 22(1):866. PubMed ID: 36404302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
    Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
    Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
    [No Abstract]   [Full Text] [Related]  

  • 5. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla
    Xu M; Fu Y; Kong H; Chen X; Chen Y; Li L; Yang Q
    BMC Infect Dis; 2018 Jul; 18(1):358. PubMed ID: 30064360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.
    Henderson H; Luterbach CL; Cober E; Richter SS; Salata RA; Kalayjian RC; Watkins RR; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; Harris A; Napravnik S; Van Duin D
    Clin Infect Dis; 2020 Apr; 70(9):1826-1833. PubMed ID: 31219148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream Infections due to Carbapenem-Resistant
    Shen L; Lian C; Zhu B; Yao Y; Yang Q; Zhou J; Zhou H
    Microb Drug Resist; 2021 Feb; 27(2):227-233. PubMed ID: 32584202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
    Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
    Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
    Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
    Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
    Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-Resistant
    Madney Y; Aboubakr S; Khedr R; Hafez H; Ahmed N; Elsheshtawy K; Elanany M; Salahelden A; Shalaby L; Galal Behairy O
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
    Liu J; Wang H; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M
    J Infect Dev Ctries; 2019 May; 13(5):357-364. PubMed ID: 32053504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Lo CL; Lee CC; Li CW; Li MC; Hsueh PR; Lee NY; Ko WC
    J Microbiol Immunol Infect; 2017 Jun; 50(3):355-361. PubMed ID: 26423244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.
    Kuo TH; Yang CY; Lee CH; Hsieh CC; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Jun; 96(26):e7075. PubMed ID: 28658101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
    Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
    Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant
    Chen L; Han X; Li Y; Li M
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069821. PubMed ID: 34228539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.